RecruitingNCT04934540

The Global En Bloc Resection of Bladder Tumour Registry


Sponsor

Chinese University of Hong Kong

Enrollment

2,000 participants

Start Date

Jan 1, 2020

Study Type

OBSERVATIONAL

Conditions

Summary

The study aims to collect data on ERBT globally in order to clarify its role in the management of bladder cancer over a 5-year observation period.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This international registry collects data on patients who undergo a newer surgical technique called en bloc resection (ERBT) to remove bladder tumors — where the tumor is cut out in one piece rather than shaved off in fragments — to evaluate outcomes and safety. **You may be eligible if...** - You are 18 or older - You have a bladder tumor and are scheduled to have ERBT (en bloc resection of bladder tumor) - You consent to participate in the registry **You may NOT be eligible if...** - You have or previously had cancer in the upper urinary tract (kidney or ureter) - You have another active cancer - You are pregnant Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREEn bloc resection of bladder tumour

En bloc resection of bladder tumour (ERBT) is a novel surgical technique in which the bladder tumour is resected in one piece


Locations(2)

North District Hospital

Hong Kong, Hong Kong

Prince of Wales Hospital

Hong Kong, Hong Kong

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04934540


Related Trials